Cervical, vaginal and endometrial cancers Gynaecological cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Women aged 18 or older diagnosed with gynaecological cancer Indication for EBRT with DHT Written informed consent
Exclusion criteria
Exclusion criteria: Any condition potentially interfering with the understanding of the study requirements, informed consent procedure and completion of questionnairesIf the vaginal lumen is <4 cm.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess whether the average vaginal temperature measured during DHT differs significantly between treatments performed with a pelotte and those with a standard vaginal probe. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reproducibility of catheter placement, patient comfort, inter-fractional spread of the vaginal temperature and the average vaginal temperature at the tip (0 cm) and 2 cm from the tip with pelotte and with a standard vaginal probe. | — |
Countries
Netherlands
Contacts
Erasmus MC, Universitair Medisch Centrum Rotterdam